Search Results - "Gewanter, Harry"

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non‐Systemic Polyarthritis, Sacroiliitis, and Enthesitis by Ringold, Sarah, Angeles‐Han, Sheila T., Beukelman, Timothy, Lovell, Daniel, Cuello, Carlos A., Becker, Mara L., Colbert, Robert A., Feldman, Brian M., Ferguson, Polly J., Gewanter, Harry, Guzman, Jaime, Horonjeff, Jennifer, Nigrovic, Peter A., Ombrello, Michael J., Passo, Murray H., Stoll, Matthew L., Rabinovich, C. Egla, Schneider, Rayfel, Halyabar, Olha, Hays, Kimberly, Shah, Amit Aakash, Sullivan, Nancy, Szymanski, Ann Marie, Turgunbaev, Marat, Turner, Amy, Reston, James

“…Objective To develop treatment recommendations for children with juvenile idiopathic arthritis manifesting as non‐systemic polyarthritis, sacroiliitis, or…”
Get full text

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non‐Systemic Polyarthritis, Sacroiliitis, and Enthesitis by Ringold, Sarah, Angeles‐Han, Sheila T., Beukelman, Timothy, Lovell, Daniel, Cuello, Carlos A., Becker, Mara L., Colbert, Robert A., Feldman, Brian M., Ferguson, Polly J., Gewanter, Harry, Guzman, Jaime, Horonjeff, Jennifer, Nigrovic, Peter A., Ombrello, Michael J., Passo, Murray H., Stoll, Matthew L., Rabinovich, C. Egla, Schneider, Rayfel, Halyabar, Olha, Hays, Kimberly, Shah, Amit Aakash, Sullivan, Nancy, Szymanski, Ann Marie, Turgunbaev, Marat, Turner, Amy, Reston, James

“…Objective To develop treatment recommendations for children with juvenile idiopathic arthritis manifesting as non‐systemic polyarthritis, sacroiliitis, or…”
Get full text

Childhood Arthritis and Rheumatology Research Alliance Biologic Disease‐Modifying Antirheumatic Drug Consensus Treatment Plans for Refractory Moderately Severe Juvenile Dermatomyositis by Tarvin, Stacey E., Sherman, Matthew A., Kim, Hanna, Balmuri, Nayimisha, Brown, Amanda G., Chow, Albert, Gewanter, Harry L., Guzman, Marietta M., Huber, Adam M., Kim, Susan, Klein‐Gitelman, Marisa S, Perron, Megan M., Robinson, Angela Byun, Sabbagh, Sara E., Savani, Sonia, Shenoi, Susan, Spitznagle, Jacob, Stingl, Cory, Syverson, Grant, Tory, Heather, Spencer, Charles, Aguiar Lapsia, Cassyanne L., Ardalan, Kaveh, Blier, Peter, Chang, Johanna, Chhabra, Amieleena, Cook, Kathryn, Curran, Megan, Fuller, Julie, Hui‐Yuen, Joyce, Lang, Bianca, Orandi, Amir B., Schmeling, Heinrike, Turnier, Jessica

“…Objective The objective was to develop consensus treatment plans (CTPs) for patients with refractory moderately severe juvenile dermatomyositis (JDM) treated…”
Get full text

Treatment escalation patterns to start biologics in refractory moderate juvenile dermatomyositis among members of the Childhood Arthritis and Rheumatology Research Alliance by Sherman, Matthew A, Kim, Hanna, Banschbach, Katelyn, Brown, Amanda, Gewanter, Harry L, Lang, Bianca, Perron, Megan, Robinson, Angela Byun, Spitznagle, Jacob, Stingl, Cory, Syverson, Grant, Tory, Heather O, Spencer, Charles H, Tarvin, Stacey E

“…Despite new and better treatments for juvenile dermatomyositis (JDM), not all patients with moderate severity disease respond adequately to first-line therapy…”
Get full text

Consensus treatments for moderate juvenile dermatomyositis: Beyond the first two months. Results of the Second Childhood Arthritis and Rheumatology Research Alliance Consensus Conference by Huber, Adam M., Robinson, Angela B., Reed, Ann M., Abramson, Leslie, Bout‐Tabaku, Sharon, Carrasco, Ruy, Curran, Megan, Feldman, Brian M., Gewanter, Harry, Griffin, Thomas, Haines, Kathleen, Hoeltzel, Mark F., Isgro, Josephine, Kahn, Philip, Lang, Bianca, Lawler, Patti, Shaham, Bracha, Schmeling, Heinrike, Scuccimarri, Rosie, Shishov, Michael, Stringer, Elizabeth, Wohrley, Julie, Ilowite, Norman T., Wallace, Carol

“…Objective To use consensus methods and the considerable expertise contained within the Childhood Arthritis and Rheumatology Research Alliance (CARRA)…”
Get full text

Novel Method to Collect Medication Adverse Events in Juvenile Arthritis: Results From the Childhood Arthritis and Rheumatology Research Alliance Enhanced Drug Safety Surveillance Project by Ringold, Sarah, Hendrickson, Audrey, Abramson, Leslie, Beukelman, Timothy, Blier, Peter R., Bohnsack, John, Chalom, Elizabeth C., Gewanter, Harry L., Gottlieb, Beth, Hollister, Roger, Hsu, Joyce, Hudgins, Andrea, Ilowite, Norman T., Klein‐Gitelman, Marisa, Lindsley, Carol, Lopez Benitez, Jorge M., Lovell, Daniel J., Mason, Tom, Milojevic, Diana, Moorthy, Lakshmi N., Nanda, Kabita, Onel, Karen, Prahalad, Sampath, Rabinovich, C. Egla, Ray, Linda, Rouster‐Stevens, Kelly, Ruth, Natasha, Shishov, Michael, Spalding, Steven, Syed, Reema, Stoll, Matthew, Vehe, Richard K., Weiss, Jennifer E., White, Andrew J., Wallace, Carol A., Sobel, Rachel E.

“…Objective Few data are available regarding the rates of serious adverse events (SAEs) and important medical events (IMEs) outside of product‐based registries…”
Get full text

2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis by Onel, Karen B., Horton, Daniel B., Lovell, Daniel J., Shenoi, Susan, Cuello, Carlos A., Angeles‐Han, Sheila T., Becker, Mara L., Cron, Randy Q., Feldman, Brian M., Ferguson, Polly J., Gewanter, Harry, Guzman, Jaime, Kimura, Yukiko, Lee, Tzielan, Murphy, Katherine, Nigrovic, Peter A., Ombrello, Michael J., Rabinovich, C. Egla, Tesher, Melissa, Twilt, Marinka, Klein‐Gitelman, Marisa, Barbar‐Smiley, Fatima, Cooper, Ashley M., Edelheit, Barbara, Gillispie‐Taylor, Miriah, Hays, Kimberly, Mannion, Melissa L., Peterson, Rosemary, Flanagan, Elaine, Saad, Nadine, Sullivan, Nancy, Szymanski, Ann Marie, Trachtman, Rebecca, Turgunbaev, Marat, Veiga, Keila, Turner, Amy S., Reston, James T.

“…Objective To provide updated guidelines for pharmacologic management of juvenile idiopathic arthritis (JIA), focusing on treatment of oligoarthritis,…”
Get full text

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis–Associated Uveitis by Angeles‐Han, Sheila T., Ringold, Sarah, Beukelman, Timothy, Lovell, Daniel, Cuello, Carlos A., Becker, Mara L., Colbert, Robert A., Feldman, Brian M., Holland, Gary N., Ferguson, Polly J., Gewanter, Harry, Guzman, Jaime, Horonjeff, Jennifer, Nigrovic, Peter A., Ombrello, Michael J., Passo, Murray H., Stoll, Matthew L., Rabinovich, C. Egla, Sen, H. Nida, Schneider, Rayfel, Halyabar, Olha, Hays, Kimberly, Shah, Amit Aakash, Sullivan, Nancy, Szymanski, Ann Marie, Turgunbaev, Marat, Turner, Amy, Reston, James

“…Objective To develop recommendations for the screening, monitoring, and treatment of uveitis in children with juvenile idiopathic arthritis (JIA). Methods…”
Get full text

Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups by Rothwell, Simon, Chinoy, Hector, Lamb, Janine A, Miller, Frederick W, Rider, Lisa G, Wedderburn, Lucy R, McHugh, Neil J, Mammen, Andrew L, Betteridge, Zoe E, Tansley, Sarah L, Bowes, John, Vencovský, Jiří, Deakin, Claire T, Dankó, Katalin, Vidya, Limaye, Selva-O'Callaghan, Albert, Pachman, Lauren M, Reed, Ann M, Molberg, Øyvind, Benveniste, Olivier, Mathiesen, Pernille R, Radstake, Timothy R D J, Doria, Andrea, de Bleecker, Jan, Lee, Annette T, Hanna, Michael G, Machado, Pedro M, Ollier, William E, Gregersen, Peter K, Padyukov, Leonid, O'Hanlon, Terrance P, Cooper, Robert G, Lundberg, Ingrid E

“…Idiopathic inflammatory myopathies (IIM) are a spectrum of rare autoimmune diseases characterised clinically by muscle weakness and heterogeneous systemic…”
Get more information

2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis by Onel, Karen B., Horton, Daniel B., Lovell, Daniel J., Shenoi, Susan, Cuello, Carlos A., Angeles‐Han, Sheila T., Becker, Mara L., Cron, Randy Q., Feldman, Brian M., Ferguson, Polly J., Gewanter, Harry, Guzman, Jaime, Kimura, Yukiko, Lee, Tzielan, Murphy, Katherine, Nigrovic, Peter A., Ombrello, Michael J., Rabinovich, C. Egla, Tesher, Melissa, Twilt, Marinka, Klein‐Gitelman, Marisa, Barbar‐Smiley, Fatima, Cooper, Ashley M., Edelheit, Barbara, Gillispie‐Taylor, Miriah, Hays, Kimberly, Mannion, Melissa L., Peterson, Rosemary, Flanagan, Elaine, Saad, Nadine, Sullivan, Nancy, Szymanski, Ann Marie, Trachtman, Rebecca, Turgunbaev, Marat, Veiga, Keila, Turner, Amy S., Reston, James T.

“…Objective To provide updated guidelines for pharmacologic management of juvenile idiopathic arthritis (JIA), focusing on treatment of oligoarthritis,…”
Get full text

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis–Associated Uveitis by Angeles‐Han, Sheila T., Ringold, Sarah, Beukelman, Timothy, Lovell, Daniel, Cuello, Carlos A., Becker, Mara L., Colbert, Robert A., Feldman, Brian M., Holland, Gary N., Ferguson, Polly J., Gewanter, Harry, Guzman, Jaime, Horonjeff, Jennifer, Nigrovic, Peter A., Ombrello, Michael J., Passo, Murray H., Stoll, Matthew L., Rabinovich, C. Egla, Sen, H. Nida, Schneider, Rayfel, Halyabar, Olha, Hays, Kimberly, Shah, Amit Aakash, Sullivan, Nancy, Szymanski, Ann Marie, Turgunbaev, Marat, Turner, Amy, Reston, James

“…Objective To develop recommendations for the screening, monitoring, and treatment of uveitis in children with juvenile idiopathic arthritis (JIA). Methods…”
Get full text

2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging by Onel, Karen B., Horton, Daniel B., Lovell, Daniel J., Shenoi, Susan, Cuello, Carlos A., Angeles‐Han, Sheila T., Becker, Mara L., Cron, Randy Q., Feldman, Brian M., Ferguson, Polly J., Gewanter, Harry, Guzman, Jaime, Kimura, Yukiko, Lee, Tzielan, Murphy, Katherine, Nigrovic, Peter A., Ombrello, Michael J., Rabinovich, C. Egla, Tesher, Melissa, Twilt, Marinka, Klein‐Gitelman, Marisa, Barbar‐Smiley, Fatima, Cooper, Ashley M., Edelheit, Barbara, Gillispie‐Taylor, Miriah, Hays, Kimberly, Mannion, Melissa L., Peterson, Rosemary, Flanagan, Elaine, Saad, Nadine, Sullivan, Nancy, Szymanski, Ann Marie, Trachtman, Rebecca, Turgunbaev, Marat, Veiga, Keila, Turner, Amy S., Reston, James T.

“…Objective To provide recommendations for the management of juvenile idiopathic arthritis (JIA) with a focus on nonpharmacologic therapies, medication…”
Get full text

Association of Anti–3‐Hydroxy‐3‐Methylglutaryl‐Coenzyme A Reductase Autoantibodies With DRB107:01 and Severe Myositis in Juvenile Myositis Patients by Kishi, Takayuki, Rider, Lisa G., Pak, Katherine, Barillas‐Arias, Lilliana, Henrickson, Michael, McCarthy, Paul L., Shaham, Bracha, Weiss, Pamela F., Horkayne‐Szakaly, Iren, Targoff, Ira N., Miller, Frederick W., Mammen, Andrew L., Abramson, Leslie S., Albert, Daniel A., Baer, Alan N., Balboni, Imelda M., Ballinger, Susan, Becker, Mara, Bingham, C. April, Bohnsack, John F., Botstein, Gary R., Carrasco, Ruy, Cartwright, Victoria W., Chao, Chun Peng T., Cron, Randy Q., Curiel, Rodolfo, DeGuzman, Marietta M., De la Pena, Wendy, Eberhard, B. Anne, Edelheit, Barbara S., Ellsworth, Janet, Finkel, Terri H., Fuhlbrigge, Robert C., Gabriel, Christos A., Gedalia, Abraham, Gewanter, Harry L., Goldmuntz, Ellen A., Goldsmith, Donald P., Gottlieb, Beth S., Graham, Brent, Griffin, Thomas A., Haftel, Hilary M., Hannan, William, Hennon, Teresa, Hoeltzel, Mark F., Hollister, J. Roger, Hopp, Russell J., Imundo, Lisa F., Jansen, Anna, Jarvis, James, Jerath, Rita S., Johnson, Courtney R., Jones, Olcay Y., Jung, Lawrence K., Kamdar, Ankur, Katona, Ildy M., Kim, Hanna, Kim, Susan, Kingsbury, Daniel J., Klein, Steven J., Lang, Bianca A., Levine, Johanan, Lindsley, Carol B., Mamyrova, Gulnara, Mitchell, Ray, Morishima, Chihiro, Moser, David W., Murphy, Frederick T., Myers, Linda K., Nanda, Kabita, Nativ, Simona, Oral, Elif A., Ostrov, Barbara E., Pappu, Ramesh, Parker, Christopher T., Passo, Murray H., Perez, Maria D., Person, Donald A., Punaro, Marilyn G., Rabinovich, C. Egla, Rennebohm, Robert M., Rivas‐Chacon, Rafael F., Ronis, Tova, Rosenkranz, Margalit, Schiffenbauer, Adam, Sheets, Robert M., Sherry, David D., Sills, Edward M., Sinal, Sara H., Stoll, Matthew, Sule, Sangeeta D., Sundel, Robert P., Vehe, Richard K., Vogelgesang, Scott A., Wargula, Jennifer C., Yung, Christine M., Zemel, Lawrence S.

“…Objective Autoantibodies recognizing 3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase (HMGCR) are associated with statin exposure, the HLA allele DRB1*11:01,…”
Get full text

Autoantibodies Recognizing Specificity Protein 4 Co‐occur With Anti–Transcription Intermediary Factor 1 and Are Associated With Distinct Clinical Features and Immunogenetic Risk Factors in Juvenile Myositis by Sherman, Matthew A., Pak, Katherine, Pinal‐Fernandez, Iago, Flegel, Willy A., Targoff, Ira N., Miller, Frederick W., Rider, Lisa G., Mammen, Andrew L., Albert, Daniel A., Arabshahi, Bita, Balboni, Imelda M., Ballinger, Susan, Bayat, Nastaran, Bingham, C. April, Bohnsack, John F., Cartwright, Victoria W., Cron, Randy Q., Curiel, Rodolfo, Pena, Wendy, Guzman, Marietta M., Eberhardt, Barbara Anne, Edelheit, Barbara S., Farhadi, Payam Noroozi, Finkel, Terri H., Fuhlbrigge, Robert C., Gewanter, Harry L., Goldmuntz, Ellen A., Gottlieb, Beth S., Griffin, Thomas A., Groh, Brandt P., Hannan, William P., Hawkins‐Holt, Melissa, Henrickson, Michael, Higgins, Gloria C., Imundo, Lisa, Jansen, Anna, Jarvis, James, Jones, Olcay Y., Kamdar, Ankur, Kim, Hanna, Kingsbury, Daniel J., Kishi, Takayuki, Lindsley, Carol B., Mamyrova, Gulnara, McCarthy, Paul L., Mitchell, Stephen R., Nanda, Kabita, Nativ, Simona, Oral, Elif A., Pachman, Lauren M., Perez, Maria D., Person, Donald A., Rabinovich, Egla C., Ronis, Tova, Sabbagh, Sara E., Sarkar, Kakali, Schiffenbauer, Adam, Shaham, Bracha, Soep, Jennifer, Stoll, Matthew L., Sule, Sangeeta, Tarvin, Stacey E., Taylor‐Albert, Elizabeth, Vogelgesang, Scott A., Volochayev, Rita, White, Patience H.

“…Objective Autoantibodies recognizing specificity protein 4 (Sp4) were recently discovered in adults with idiopathic inflammatory myopathies (IIM). Anti‐Sp4…”
Get full text

Global survey of physicians’ attitudes toward biologic and biosimilar therapies by Molinari, Anna L, Gewanter, Harry L, Loaiza-Bonilla, Arturo, Reilly, Michael, Kennedy, Brian, Charles, David

“…Abstract only…”
Get full text

2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging by Onel, Karen B., Horton, Daniel B., Lovell, Daniel J., Shenoi, Susan, Cuello, Carlos A., Angeles‐Han, Sheila T., Becker, Mara L., Cron, Randy Q., Feldman, Brian M., Ferguson, Polly J., Gewanter, Harry, Guzman, Jaime, Kimura, Yukiko, Lee, Tzielan, Murphy, Katherine, Nigrovic, Peter A., Ombrello, Michael J., Rabinovich, C. Egla, Tesher, Melissa, Twilt, Marinka, Klein‐Gitelman, Marisa, Barbar‐Smiley, Fatima, Cooper, Ashley M., Edelheit, Barbara, Gillispie‐Taylor, Miriah, Hays, Kimberly, Mannion, Melissa L., Peterson, Rosemary, Flanagan, Elaine, Saad, Nadine, Sullivan, Nancy, Szymanski, Ann Marie, Trachtman, Rebecca, Turgunbaev, Marat, Veiga, Keila, Turner, Amy S., Reston, James T.

“…Objective To provide recommendations for the management of juvenile idiopathic arthritis (JIA) with a focus on nonpharmacologic therapies, medication…”
Get full text

Anti-FHL1 autoantibodies in juvenile myositis are associated with anti-Ro52 autoantibodies but not with severe disease features by Sherman, Matthew A, Graf, Rose, Sabbagh, Sara E, Galindo-Feria, Angeles S, Pinal-Fernandez, Iago, Pak, Katherine, Kishi, Takayuki, Flegel, Willy A, Targoff, Ira N, Miller, Frederick W, Lundberg, Ingrid E, Rider, Lisa G, Mammen, Andrew L

“…Four-and-a-half LIM domains 1 (FHL1) is a muscle-specific protein. Autoantibodies against FHL1 were recently discovered in adults with idiopathic inflammatory…”
Get full text

2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis (JIA): Recommendations for Non-Pharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging by Onel, Karen B., Horton, Daniel B., Lovell, Daniel J., Shenoi, Susan, Cuello, Carlos A., Angeles-Han, Sheila T., Becker, Mara L., Cron, Randy Q., Feldman, Brian M., Ferguson, Polly J., Gewanter, Harry, Guzman, Jaime, Kimura, Yukiko, Lee, Tzielan, Murphy, Katherine, Nigrovic, Peter A., Ombrello, Michael J., Rabinovich, C. Egla, Tesher, Melissa, Twilt, Marinka, Klein-Gitelman, Marisa, Barbar-Smiley, Fatima, Cooper, Ashley M., Edelheit, Barbara, Gillispie-Taylor, Miriah, Hays, Kimberly, Mannion, Melissa L., Peterson, Rosemary, Flanagan, Elaine, Saad, Nadine, Sullivan, Nancy, Szymanski, Ann Marie, Trachtman, Rebecca, Turgunbaev, Marat, Veiga, Keila, Turner, Amy S., Reston, James T.

Get full text

Multi-pronged approach to enhance education of children and adolescents with lupus, caregivers, and healthcare providers in New Jersey: Needs assessment, evaluation, and development of educational materials by Hovde, Aldina M, McFarland, Cheryl AS, Garcia, G Melissa, Gallagher, Fran, Gewanter, Harry, Klein-Gitelman, Marisa, Moorthy, L Nandini

“…Background Childhood Systemic Lupus Erythematosus (cSLE) patients are younger at diagnosis and have a more severe disease course compared to adult onset SLE…”
Get full text

Medications received by patients with juvenile dermatomyositis by Kishi, Takayuki, Bayat, Nastaran, Ward, Michael M., Huber, Adam M., Wu, Lan, Mamyrova, Gulnara, Targoff, Ira N., Warren-Hicks, William J., Miller, Frederick W., Rider, Lisa G.

“…Few controlled studies are available to guide treatment decisions in juvenile dermatomyositis (JDM). This study evaluated therapies received, changes of…”
Get full text